ACHV Earnings Date: Nov 5, 2026 (Estimated) — Achieve Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is ACHV's next earnings date?
Achieve Life Sciences, Inc. (ACHV) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20 on revenue of $10.6M.
How did ACHV do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Achieve Life Sciences, Inc. posted EPS of -$0.80 versus the -$0.16 estimate, a miss of 400.0%. Revenue was $0. The stock's 1-day post-earnings move was +1.5%.
How much does ACHV stock move after earnings?
ACHV beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.8% (up or down) in the day after earnings.
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.16 | -0.80 | -400.00% | $0 | ❌ Miss | +1.50% | +12.44% | +13.04% |
| 2026-05-12 | Q1 2026 | -0.30 | -0.19 | +36.67% | $0 | ✅ Beat | +7.16% | -14.67% | +2.86% |
| 2026-03-24 | Q4 2025 | -0.27 | -0.28 | -3.70% | $0 | ❌ Miss | -28.40% | -34.07% | +4.44% |
| 2025-11-06 | Q3 2025 | -0.25 | -0.28 | -12.00% | $0 | ❌ Miss | -3.85% | -4.26% | -6.29% |
| 2025-03-11 | Q4 2024 | -0.36 | -0.36 | +0.00% | $0 | ➖ Inline | -4.58% | -4.90% | -35.46% |
| 2024-11-07 | Q3 2024 | -0.26 | -0.36 | -38.46% | $0 | ❌ Miss | -7.40% | -12.20% | -8.80% |
| 2024-08-13 | Q2 2024 | -0.23 | -0.25 | -8.70% | $0 | ❌ Miss | +0.57% | +1.26% | -0.11% |
| 2024-03-28 | Q4 2023 | -0.31 | -0.26 | +16.13% | $0 | ✅ Beat | +0.77% | -1.87% | +0.55% |
Showing last 8 quarters.